Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

Please sign in to follow a disease.

← Back to home

Mohammed Milhem

Clinical trials sponsored by Mohammed Milhem, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New triple-drug combo shows promise for advanced kidney cancer Results expected Dec 2026 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 1 Not yet finished but already full! 2 Completed 3

New combo aims to revive immunotherapy in resistant cancers

Disease control Recruiting now

This early-stage trial tests whether adding a chemotherapy drug (5-Azacitidine) to standard immunotherapy can help patients whose solid tumors have stopped responding to PD-1/PD-L1 inhibitors. About 35 adults with advanced or metastatic cancers will receive the combination to fin…

Phase 1 • Sponsor: Mohammed Milhem • Aim: Disease control

Last updated Jun 27, 2026 12:38 UTC